Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]
Sultan Qaboos Univ Med JBlastic plasmacytoid dendritic cell neoplasm is an uncommon, aggressive hematologic neoplasm carrying a poor prognosis with a median survival of one year, making early detection vital. Patients present with a number of characteristic cutaneous manifestations and are treated with chemotherapy and hematopoietic stem cell transplantation, which may ...
Kravchenko DV +9 more
europepmc +16 more sources
Blastic plasmacytoid dendritic cell neoplasm [PDF]
Anais Brasileiros de Dermatologia, 2013 Blastic plasmacytoid dendritic cell neoplasm is a rare and aggressive hematodermic neoplasia with frequent cutaneous involvement and leukemic dissemination.
André Lencastre +5 more
doaj +14 more sources
Blastic Plasmacytoid Dendritic-Cell Neoplasm [PDF]
New England Journal of Medicine, 2020 Blastic Plasmacytoid Dendritic-Cell Neoplasm A 29-year-old man presented with progressive skin lesions on the face, back, trunk, and limbs.
Yung Gonzaga, Mayne Fontes
core +15 more sources
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent [PDF]
Haematologica, 2015 Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy derived from plasmacytoid dendritic cells. There is currently no accepted standard of care for treating this neoplasm, and therapeutic strategies have never been prospectively ...
Fanny Angelot-Delettre +20 more
doaj +4 more sources
Juvenile Blastic Plasmacytoid Dendritic Cell Neoplasm
Acta Dermato-Venereologica, 2020 is missing (Short communication)
Kinan M. Hayani +4 more
doaj +3 more sources
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm [PDF]
Haematologica, 2023 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that presents with characteristic dark purple skin papules, plaques, and tumors, but may also involve the bone marrow, blood, lymph nodes, and central nervous system ...
Marlise R. Luskin, Andrew A. Lane
doaj +2 more sources
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature [PDF]
Journal of Medical Case Reports, 2021 Background We describe a patient with blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement and the outcome of venetoclax use in this setting.
Nil Albiol +5 more
doaj +2 more sources
Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]
Kansas Journal of Medicine, 2014 Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It manifests as cutaneous and bone marrow involvement and leukemic spread. It represents 0.7% of primary cutaneous lymphomas. Recently, it was established as a distinct entity.
Rami Jabbour +3 more
core +4 more sources
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target [PDF]
Haematologica, 2019 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy for which there is still no effective therapy. In order to identify genetic alterations useful for a new treatment design, we used whole-exome sequencing
Maria Rosaria Sapienza +30 more
doaj +4 more sources
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects [PDF]
Cancers, 2019 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which usually a_ects elderly males and presents in the skin with frequent involvement of the bone-marrow, peripheral blood and lymph nodes.
Maria Rosaria Sapienza +2 more
exaly +3 more sources